Navigation Links
EU awards $4 million for pneumonia research
Date:5/11/2009

Pneumonia infections are not only a problem of developing countries. In Germany more than 60,000 people die annually due to this disease, which is mostly caused by the bacterial species Streptococcus pneumoniae. Combating pneumococcal infections is getting more and more difficult and current vaccines mediate only partial protection.

13 international research institutions representing 10 countries in Asia, Europe and South America have joined forces with the aim to develop new antibiotics and vaccines to fight pneumococcal infection. The department of Microbial Pathogenicity of the Helmholtz Centre for Infection Research (HZI) in Braunschweig is coordinator of the project named "CAREPNEUMO", which is running for three years and funded with 3 Million Euro by EU.

Antibiotic resistant bacterial pathogens are a serious problem: many drugs which successfully eliminated an infection in the past have become ineffective. The emergence of multiresistant bacteria is a severe problem and a variety of antibiotics are now ineffective. Singh Chhatwal, head of the department "Microbial Pathogenicity" at the HZI: "In France and Spain, about half of the pneumococcal isolates are resistant against at least one antibiotic".

The two currently available pneumococcal vaccines have the disadvantage that not all of the more than 90 pneumococcal subspecies, named serotypes, are covered. Prof. Singh Chhatwal said "while vaccination reduces spreading of these seven serotypes it has unfortunately led to appearance of uncommon pneumococcal serotypes. In addition, in Germany and United States for example, the prevalent serotypes are different to those serotypes commonly found in India, which complicates worldwide treatment and prevention strategies. "Therefore, we have to find alternatives for treatment and prevention of pneumococcal infections", says Singh Chhatwal. For this reason, he has initiated the research consortium CAREPNEUMO.

The objectives of the consortium is divided into three research projects: At first, scientists want to identify and characterize pneumococcal serotypes, which are of main importance worldwide. Afterwards, pneumococcal escape of human immune system and induction of pneumonia will be investigated. Then, based on the acquired knowledge, new therapies, antibiotics and vaccines will be developed.


'/>"/>

Contact: Dr. Bastian Dornbach
bad@helmholtz-hzi.de
49-053-161-811-407
Helmholtz Association of German Research Centres
Source:Eurekalert

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Good Clinical Practice Journal Awards: Winners Announced
3. NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
4. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
5. 2007 EURYI: 20 researchers to receive Nobel Prize-sized awards in Helsinki
6. HRET Awards Four Health Career Scholarships
7. Portico Systems Wins Three Awards in 30 Days
8. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
9. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
10. The Sisters of Charity Health System Awards Four Nursing Scholarships in Ohio and South Carolina
11. U.S. Labor Department Awards $10.1 Million for Safety and Health Training Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... Using the power of the internet, ... online checklist. Over a period of just 24 months, thousands of individuals interested in ... checklist called T.A.D. , “The internet is not getting quieter. In fact it’s becoming ...
(Date:2/22/2017)... ... ... ANGLESTRONG , the new recovery management app with multiple innovative features ... and Google Play . Florida-based Sober Network, Inc., the premier provider of ... Angle to build ANGLESTRONG. The new recovery management app is a passion project for ...
(Date:2/22/2017)... MADISON HEIGHTS, MICHIGAN (PRWEB) , ... February 22, ... ... news and analysis of issues related to spine practices, is featuring Michigan neurosurgeon ... Jagannathan is known as one of a small number of neurosurgeons in Michigan ...
(Date:2/22/2017)... ... ... A product of digesting a micronutrient found in soy may hold the key ... while others do not, a University of Pittsburgh Graduate School of Public Health-led study ... some types of “good” gut bacteria when they metabolize isoflavones (micronutrients found in dietary ...
(Date:2/22/2017)... Staefa, Switzerland (PRWEB) , ... February 22, 2017 ... ... have difficulty hearing and 72 percent of those report that family members or ... those who think they suffer from hearing loss wear hearing aids. One reason, ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 LG Innotek today announced that the company ... As its sterilization performance is 1.5 times higher than the competitor,s ... rays in the range of 200 -- 280nm, allowing it to be ... destroying their DNA. LG Innotek,s product emits UV in the range ... Until ...
(Date:2/23/2017)... -- Tillotts Pharma is strengthening its presence ... office was opened in January 2017 under the ... Entocort ® for the treatment of Crohn,s disease, ... and VistaPrep ® for bowel preparation before endoscopy. ... focused on the treatment of gastrointestinal (GI) diseases will ...
(Date:2/23/2017)... YORK , February 23, 2017 ... states have legalized cannabis for recreational use in 2016. According ... legal cannabis market was worth an estimated $7.2 billion in ... growth rate of 17%. While adult recreational sales are projected ... by 2020, with a 25% CAGR. The market may grow ...
Breaking Medicine Technology: